Skip to main content

Naftifine Hydrochloride

Generic: Naftifine Hydrochloride

Verified·Apr 23, 2026
Manufacturer
Sebela
NDC
51672-1362
ICD-10 indication
B35.9

Affordability Check

How much will you actually pay for Naftifine Hydrochloride?

In 30 seconds, see every legitimate way to afford Naftifine Hydrochloride — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Naftifine Hydrochloride

What is this medication? Naftifine hydrochloride is a prescription antifungal medication used to treat fungal skin infections. It is specifically formulated to address conditions such as tinea pedis, commonly known as athlete's foot, as well as tinea cruris, known as jock itch, and tinea corporis, known as ringworm. As an allylamine antifungal, it works by interfering with the synthesis of sterols in the fungi, which ultimately prevents the fungus from growing and spreading across the skin's surface.

The medication is applied topically as a cream or gel to the infected area, typically once or twice a day as directed by a healthcare provider. By targeting the fungal cell membranes, naftifine hydrochloride helps to relieve the discomfort associated with these infections, including redness, peeling, and intense itching. It is essential for patients to complete the full course of treatment even if the skin appears to be healing to ensure that the infection does not recur.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Naftifine Hydrochloride. Official source: DailyMed (NLM) · Label effective Jul 7, 2025

Indications and usage
INDICATIONS AND USAGE Naftifine Hydrochloride Cream USP, 1% is indicated for the topical treatment of tinea pedis, tinea cruris and tinea corporis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum .
Dosage and administration
DOSAGE AND ADMINISTRATION A sufficient quantity of Naftifine Hydrochloride Cream USP, 1% should be gently massaged into the affected and surrounding skin areas once a day. The hands should be washed after application. If no clinical improvement is seen after four weeks of treatment with Naftifine Hydrochloride Cream USP, 1%, the patient should be re-evaluated.
Contraindications
CONTRAINDICATIONS Naftifine Hydrochloride Cream USP, 1% is contraindicated in individuals who have shown hypersensitivity to any of its components.
Warnings
WARNINGS Naftifine Hydrochloride Cream USP, 1% is for topical use only and not for ophthalmic use.
Adverse reactions
ADVERSE REACTIONS During clinical trials with Naftifine Hydrochloride Cream USP, 1%, the incidence of adverse reactions was as follows: burning/stinging (6%), dryness (3%), erythema (2%), itching (2%), local irritation (2%).
Use in pregnancy
Pregnancy Teratogenic Effects Reproduction studies have been performed in rats and rabbits (via oral administration) at doses 150 times or more than the topical human dose and have revealed no evidence of impaired fertility or harm to the fetus due to naftifine. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Naftifine Hydrochloride appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

15%

806 of 5,509 plans

Most common tier

Tier 4

On 70% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)10
20%
Tier 2 (generic)3
6%
Tier 3 (preferred brand)2
4%
Tier 4 (non-preferred brand)35
70%

Step therapy: 2% of formularies

Quantity limits: 68% of formularies

Coverage breadth: 50 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.